Form 4: Arteris CEO Sells Shares for Tax Withholding

Arteris Inc. President and CEO K. Charles Janac reported the sale of common stock to cover tax liabilities related to restricted stock unit releases, with some transactions executed under a 10b5-1 plan.

Summary

• K. Charles Janac, President and CEO of Arteris, Inc., reported transactions involving the sale of common stock on April 2nd and April 6th, 2026.
• These sales were primarily to satisfy tax liabilities arising from the release of restricted stock units, a process mandated by the company's equity incentive plans.
• A portion of the sales on April 6th, totaling 11,800 shares, were conducted under a Rule 10b5-1 trading plan adopted on March 5th, 2025.
• The weighted average sale price for the April 6th transactions was $18.3394, with individual sales ranging from $18.20 to $18.63.
• Following these transactions, Janac's direct beneficial ownership of common stock decreased, while indirect ownership through Bayview Legacy, LLC and the Charles and Lydia Janac Trust remains significant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider selling can be a negative signal, the clear explanation of tax liabilities and the use of a 10b5-1 plan mitigate significant concern.

Positives

• The sales were executed to cover tax liabilities, a standard procedure for restricted stock unit releases, indicating compliance with tax obligations.
• The use of a Rule 10b5-1 trading plan for some transactions suggests a pre-planned and orderly approach to managing stock sales, potentially mitigating concerns about insider trading.
• The company has a mechanism in place (sell-to-cover) to manage tax withholding obligations related to equity compensation.

Negatives

• The CEO sold a significant number of shares, which could be perceived negatively by the market, even though it's for tax purposes.
• The weighted average sale price of $18.3394 on April 6th is lower than the reported direct ownership of 215,920 shares at a price of $17.6528 on April 2nd, though this reflects different transaction types and timing.

Risks

• Potential for negative market perception due to insider selling, even if for tax reasons.
• The company's reliance on 'sell to cover' transactions for tax withholding could be impacted by stock price volatility if the market price falls below the tax liability threshold.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• Sales were mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction.
• These sales do not represent discretionary trades by the Reporting Person.
• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 upon request.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine for executives and directors, often related to managing equity compensation. The use of 10b5-1 plans is a common strategy to diversify holdings and manage tax obligations without triggering insider trading concerns, especially in the technology sector where equity-based compensation is prevalent.

Stakeholder Impact

• Shareholders: May observe a reduction in the CEO's direct shareholding, but the explanation for tax purposes and the use of a 10b5-1 plan should temper concerns about a lack of confidence in the company.

Next Steps

• The Reporting Person may provide further information regarding share sales upon request from the SEC, security holders, or the Issuer.

Key Dates

Keywords

Arteris Inc., K. Charles Janac, Form 4, Insider Trading, Stock Sale, Tax Liability, Restricted Stock Units, 10b5-1 Plan, Beneficial Ownership, SEC Filing